# olopatadine hydrochloride

NDC: 45802-104
Generic name: Olopatadine Hydrochloride
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SPRAY
Routes: NASAL
Marketing started: 20170614

FDA application: ANDA202853

## Active ingredients

- OLOPATADINE HYDROCHLORIDE: 665 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-104"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-104
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=126ff6eb-62ae-46f2-ab1e-7ac19346c36b